Glenn Russell Dubin is one of the industry's most experienced hedge fund managers, best known as the co-founder of Highbridge Capital Management, a multi-strategy investment business...
Keep Reading →
May 10 - Hedge Funds, Industries, News
Major US indexes finished in the green on Wednesday, May 7, after a volatile session as investors reacted to updates from the Federal Reserve and new trade developments.
Keep Reading →
May 8 - Hedge Funds, Industries, News
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q1 2025 Earnings Call Transcript May 6, 2025Sarepta Therapeutics, Inc. misses on earnings expectations.
Keep Reading →
May 7 - News, Transcripts
On April 28, Darrell Cronk, Wells Fargo Wealth and Investment Management CIO, appeared on CNBC's 'Squawk on the Street' to discuss market outlooks and what investors should look...
Keep Reading →
April 29 - Hedge Funds, News
When a legendary investor like George Soros makes a move, Wall Street pays attention.
Keep Reading →
April 23 - News, Stock Analysis
On March 31, Banrion's Shana Sissel recently appeared on CNBC's 'Power Lunch' to discuss that buying at lower valuations is favorable for long-term investors.
Keep Reading →
April 21 - Hedge Funds, News
On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC's 'Power Lunch' to discuss investing in biotech and the oversaturation in the sector.
Keep Reading →
March 26 - Hedge Funds, Industries, News
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q4 2024 Earnings Call Transcript February 26, 2025Sarepta Therapeutics, Inc. beats earnings expectations.
Keep Reading →
February 27 - News, Transcripts
While stocks initially fell based on worries regarding Trump tariffs on America’s major trading partners, major indexes recovered from their initial losses as the President ...
Keep Reading →
February 24 - Hedge Funds, News
In the fourth quarter of 2024, the US Gross Domestic Product (GDP) expanded at an annual rate of 2.3%, slightly below market expectations of 2.7% and a deceleration from the 3...
Keep Reading →
February 20 - Hedge Funds, News
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
Keep Reading →
February 7 - Hedge Funds, Industries, News
Jim Cramer, the host of Mad Money, recently expressed his concerns about the uncertain economic outlook for 2025, particularly in relation to corporate earnings and the stock ...
Keep Reading →
January 31 - Hedge Funds, News
We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Disruptive analytics’ Substack by Magnus Ofstad.
Keep Reading →
January 20 - News, Stock Analysis
Gene therapy is referred to as a medical technique that involves modifying or manipulating genes to treat or prevent disease.
Keep Reading →
December 28 - Hedge Funds, Industries, News
The biotechnology sector is expanding quickly due to rising demand for novel therapies, advancement in technology, and government assistance.
Keep Reading →
December 23 - Hedge Funds, News
We came across a bullish thesis on Sarepta Therapeutics, Inc. (SRPT) on Substack by Two Natural Capital. In this article, we will summarize the bulls’ thesis on SRPT.
Keep Reading →
December 14 - News, Stock Analysis
BlackRock highlighted that its portfolio managers are broadly optimistic about US equities.
Keep Reading →
November 14 - Hedge Funds, News
Operator: Good day and welcome to the Sarepta Therapeutics Third Quarter 2024 Financial Results Conference Call.
Keep Reading →
November 8 - News, Transcripts
In the current climate of extreme market volatility, finding safe and stable investments is challenging.
Keep Reading →
October 27 - Hedge Funds, News
Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.
Keep Reading →
October 11 - Hedge Funds, Industries, News
The Fed recently cut the funds rate by 50 basis points which has been considered a bold move by some analysts while others and most of the market have welcomed it with open arms...
Keep Reading →
September 29 - Hedge Funds, News
The ability to successfully make money through investment requires deep thinking and analysis.
Keep Reading →
September 11 - Hedge Funds, News
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2024 Earnings Call Transcript August 7, 2024Sarepta Therapeutics, Inc. beats earnings expectations.
Keep Reading →
August 8 - News, Transcripts
We came across a bullish thesis on Sarepta Therapeutics (SRPT) on X (formerly Twittter) by user quantumup. In this article we will summarize the bulls' thesis on SRPT.
Keep Reading →
August 1 - News, Stock Analysis
We recently compiled the list of the 10 Best Fast Growth Stocks To Buy according to the hedge funds using the latest sentiment data.
Keep Reading →
May 29 - Hedge Funds, News
Growth stocks are those that are either growing their revenue in mid to high double or triple digit percentages or those who trade at significantly higher prices when compared...
Keep Reading →
May 28 - News, Quantitative Investing
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.37, expectations were $-0.11. Sarepta Therapeutics, Inc.
Keep Reading →
May 2 - News, Transcripts
In this article, we discuss the 5 unstoppable stocks that will make you richer.
Keep Reading →
April 13 - News
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
Keep Reading →
March 17 - Lists, News
In this article, we will take a detailed look at Billionaire Ken Fisher and Corporate Insiders Are Buying These 10 Stocks.
Keep Reading →
March 14 - Hedge Funds, Insider Trading, News
In this article, we will take a detailed look at Billionaire Ray Dalio and Insiders Love These 10 Stocks. For a quick overview of such stocks, read our article Billionaire Ray...
Keep Reading →
March 11 - Hedge Funds, Insider Trading, News
Sarepta Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.47, expectations were $-0.03. Sarepta Therapeutics, Inc.
Keep Reading →
February 29 - News, Transcripts
In this piece, we will take a look at the five best small-cap growth stocks to invest in.
Keep Reading →
February 22 - Hedge Funds, News
In this article, we will take a look at the 15 stocks with at least 30% annual growth rates to consider for a growth stock portfolio.
Keep Reading →
January 22 - Hedge Funds, News
This article presents an overview of the 5 Best Mid-Cap Growth Stocks To Buy Now.
Keep Reading →
January 12 - Hedge Funds, News
In this article, we will take a look at the 15 best fast growth stocks to buy now.
Keep Reading →
December 27 - Hedge Funds, News
In this article, we will take a look at 13 high growth healthcare stocks to buy.
Keep Reading →
December 26 - Hedge Funds, News
This article presents an overview of the 5 Stocks Insiders and Billionaires Are Crazy About. For a detailed overview of such stocks, read our article, 11 Stocks Insiders ...
Keep Reading →
December 19 - Hedge Funds, News
In this article, we will take a look at the 10 beaten down stocks billionaires are crazy about.
Keep Reading →
December 12 - Hedge Funds, News
In this piece, we will take a look at the five best upside stocks to buy right now.
Keep Reading →
November 27 - Hedge Funds, News
With the end of 2023 now in sight, many can say with confidence that the much-dreaded recession everyone was talking about will not realize this year.
Keep Reading →
November 24 - Hedge Funds, News
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
November 7 - Hedge Fund Investor Letters, News
Operator: Good afternoon and welcome to the Sarepta Therapeutics Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
Keep Reading →
November 2 - News, Transcripts
In this article, we discuss the 5 stocks receiving downgrades from analysts.
Keep Reading →
November 1 - Market Movers, News
In this piece, we will take a look at the five best long term stocks to buy for high returns.
Keep Reading →
October 30 - Hedge Funds, News
Operator: Good afternoon and welcome to the Sarepta Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
Keep Reading →
August 4 - News, Transcripts
In this article, we will take a look at the 10 oversold biotech stocks to buy.
Keep Reading →
July 29 - Hedge Funds, Lists, Market Movers
In this piece, we will take a look at the five best economic recovery stocks to buy.
Keep Reading →
July 12 - News
In this article, we discuss 5 best healthcare stocks billionaires are loading up on.
Keep Reading →
June 8 - Hedge Funds, News
In the midst of uncertain economic conditions globally, the healthcare sector has displayed a notable degree of resilience.
Keep Reading →
June 1 - Hedge Funds, News
